Epidemiological Features and Resistance Pattern in Uropathogens Isolated from Chronic Bacterial Prostatitis

被引:39
作者
Cai, Tommaso [1 ]
Mazzoli, Sandra [2 ]
Meacci, Francesca [2 ]
Boddi, Vieri [4 ]
Mondaini, Nicola [3 ]
Malossini, Gianni [1 ]
Bartoletti, Riccardo [3 ]
机构
[1] Santa Chiara Hosp, Dept Urol, I-38123 Trento, Italy
[2] Santa Maria Annunziata Hosp, Sexually Transmitted Dis Ctr, I-50011 Florence, Italy
[3] Univ Florence, Dept Urol, I-50011 Florence, Italy
[4] Univ Florence, Dept Publ Hlth & Epidemiol, I-50011 Florence, Italy
关键词
bacterial prostatitis; Gram-positive; Gram-negative; antibacterial agents; antibiotic susceptibility; URINARY-TRACT-INFECTIONS; CHLAMYDIA-TRACHOMATIS; MANAGEMENT; CIPROFLOXACIN; QUALITY; THERAPY; IMPACT;
D O I
10.1007/s12275-011-0391-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic bacterial prostatitis (CBP) is, usually, caused by uropathogens, especially gram-negative bacilli, although infection is sometimes due to Gram-positive and atypical microorganisms. A recent increasing in prevalence of Gram-positive strains has been reported. The aim of this study was to explore the epidemiological features and resistance rates in uropathogens isolated from CBP outpatients in last 10 years. All consecutive outpatients with demonstrated CBP attending a single Sexually Transmitted Disease centre from January 1997 and December 2008, were enrolled and underwent microbiological cultures in first void early morning urine, midstream urine, expressed prostatic secretion, and post prostate massage urine. Prevalence of different bacterial strains was stratified in four different periods: 1997-1999, 2000-2002, 2003-2005, 2006-2008. Any changes observed in epidemiological features and resistance rates in uropathogens over the whole study period have been analyzed. The present study has been planned, thus, as in vitro study. From 6,221 patients, 4,601 Gram-positive and 1,620 Gram-negative bacterial strains have been isolated. Enterococcus faecalis and Escherichia coli strains are the first and second frequent pathogens found, respectively. Significant differences between E. faecalis prevalence in the 1997-1999 and 2006-2008 periods were found. E. coli showed a significant difference between prevalence in 1997-1999 and 2006-2008 periods. Gram-positive organisms showed a decreasing of susceptibility to ciprofloxacin as well as Grain-negative strains, while a good susceptibility to the levofloxacin was evidenced. E. faecalis prevalence seemed to be raised in 2006-2008 periods. Moreover, a decreasing of activity of ciprofloxacin and a good activity profile of levofloxacin have been reported.
引用
收藏
页码:448 / 454
页数:7
相关论文
共 28 条
[1]   Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey [J].
Arslan, H ;
Azap, ÖK ;
Ergönül, Ö ;
Timurkaynak, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :914-918
[2]   Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: A randomized double-blind multicenter study [J].
Bundrick, W ;
Heron, SP ;
Ray, P ;
Schiff, WM ;
Tennenberg, AM ;
Wiesinger, BA ;
Wright, PA ;
Wu, SC ;
Zadeikis, N ;
Kahn, JB .
UROLOGY, 2003, 62 (03) :537-541
[3]   Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients [J].
Dario Motrich, Ruben ;
Cuffini, Cecilia ;
Mackern Oberti, Juan Pablo ;
Maccioni, Mariana ;
Elena Rivero, Virginia .
JOURNAL OF INFECTION, 2006, 53 (03) :175-183
[4]   A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin [J].
Drusano, GL ;
Preston, SL ;
Van Guilder, M ;
North, D ;
Gombert, M ;
Oefelein, M ;
Boccumini, L ;
Weisinger, B ;
Corrado, M ;
Kahn, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2046-2051
[5]   Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli [J].
Ena, Javier ;
Arjona, Francisco ;
Martinez-Peinado, Carmen ;
Lopez-Perezagua, Maria Del Mar ;
Amador, Concepcion .
UROLOGY, 2006, 68 (06) :1169-1174
[6]   Antimicrobial therapy for bacterial and nonbacterial prostatitis [J].
Fowler, JE .
UROLOGY, 2002, 60 (6A) :24-26
[7]   The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index [J].
Giubilei, G ;
Mondaini, N ;
Crisci, A ;
Raugei, A ;
Lombardi, G ;
Travaglini, F ;
Del Popolo, G ;
Bartoletti, R .
EUROPEAN UROLOGY, 2005, 47 (06) :805-811
[8]  
Krieger J N, 2004, Minerva Urol Nefrol, V56, P99
[9]   Epidemiology of prostatitis: new evidence for a world-wide problem [J].
Krieger, JN ;
Riley, DE ;
Cheah, PY ;
Liong, ML ;
Yuen, KH .
WORLD JOURNAL OF UROLOGY, 2003, 21 (02) :70-74
[10]   NIH consensus definition and classification of prostatitis [J].
Krieger, JN ;
Nyberg, L ;
Nickel, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :236-237